文献速递炎症性肠病

健康个体中针对肠道菌群的循环和组织驻留CD4+ T细胞丰富,且炎症时功能发生改变

Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation.
PubMed 文献 · Gastroenterology · 2017-08-04

研究比较健康对照与炎症性肠病患者外周血和肠道组织中针对9种肠道细菌的CD4+ T细胞反应,发现对照中此类细胞频率为每百万40-4000个,以记忆表型为主、TCR Vβ多样,可产生屏障保护性细胞因子;IBD患者血中菌群反应性CD4+ T细胞较肠道减少,且白介素17A产生频率增加。

要点

  • 健康人循环和肠道CD4+ T细胞对每种受试细菌反应频率为每百万40-4000个。
  • 菌群反应性CD4+ T细胞主要为记忆表型,TCR Vβ repertoire多样,功能异质。
  • IBD患者血中菌群反应性CD4+ T细胞较肠道减少,白介素17A产生频率增加。

核心结论

  • 对肠道细菌的反应性是人CD4+ T细胞库的正常特性,不一定提示免疫细胞与共生菌群相互作用受损。
  • 对共生菌的T细胞反应可能通过产生屏障保护性细胞因子和提供大量针对病原体的T细胞池来支持肠道稳态。

研究设计与样本

  • 收集健康对照(n=13-30)和炎症性肠病患者(n=119;溃疡性结肠炎59例,克罗恩病60例)的外周血单核细胞和肠道组织样本。
  • 采用2种独立检测方法(CD154检测和羧基荧光素琥珀酰亚胺酯稀释试验)和9种肠道细菌物种定量、扩增和表征菌群反应性CD4+ T细胞。
  • 对扩增的菌群反应性T细胞系进行T细胞受体Vβ基因测序以确定克隆多样性。
  • 检测菌群反应性CD4+ T细胞对肠道基质和上皮细胞系的影响,并通过流式细胞术和定量聚合酶链反应测量细胞因子、趋化因子和基因表达模式。

主要发现

  • 对照的循环和肠道CD4+ T细胞对每种受试细菌的反应频率为每百万40-4000个。
  • 菌群反应性CD4+ T细胞主要呈记忆表型,存在于外周血单核细胞和肠道组织中,T细胞受体Vβ库多样。
  • 这些细胞功能异质,产生屏障保护性细胞因子,并通过白介素17A、干扰素γ和肿瘤坏死因子刺激肠道基质和上皮细胞。
  • 在炎症性肠病患者中,菌群反应性CD4+ T细胞在血中较肠道减少;检测到的T细胞反应中白介素17A产生频率较对照的血或肠道组织T细胞反应增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Interactions between commensal microbes and the immune system are tightly regulated and maintain intestinal homeostasis, but little is known about these interactions in humans. We investigated responses of human CD4+ T cells to the intestinal microbiota. We measured the abundance of T cells in circulation and intestinal tissues that respond to intestinal microbes and determined their clonal diversity. We also assessed their functional phenotypes and effects on intestinal resident cell populations, and studied alterations in microbe-reactive T cells in patients with chronic intestinal inflammation. METHODS: We collected samples of peripheral blood mononuclear cells and intestinal tissues from healthy individuals (controls, n = 13-30) and patients with inflammatory bowel diseases (n = 119; 59 with ulcerative colitis and 60 with Crohn's disease). We used 2 independent assays (CD154 detection and carboxy-fluorescein succinimidyl ester dilution assays) and 9 intestinal bacterial species (Escherichia coli, Lactobacillus acidophilus, Bifidobacterium animalis subsp lactis, Faecalibacterium prausnitzii, Bacteroides vulgatus, Roseburia intestinalis, Ruminococcus obeum, Salmonella typhimurium, and Clostridium difficile) to quantify, expand, and characterize microbe-reactive CD4+ T cells. We sequenced T-cell receptor Vβ genes in expanded microbe-reactive T-cell lines to determine their clonal diversity. We examined the effects of microbe-reactive CD4+ T cells on intestinal stromal and epithelial cell lines. Cytokines, chemokines, and gene expression patterns were measured by flow cytometry and quantitative polymerase chain reaction. RESULTS: Circulating and gut-resident CD4+ T cells from controls responded to bacteria at frequencies of 40-4000 per million for each bacterial species tested. Microbiota-reactive CD4+ T cells were mainly of a memory phenotype, present in peripheral blood mononuclear cells and intestinal tissue, and had a diverse T-cell receptor Vβ repertoire. These cells were functionally heterogeneous, produced barrier-protective cytokines, and stimulated intestinal stromal and epithelial cells via interleukin 17A, interferon gamma, and tumor necrosis factor. In patients with inflammatory bowel diseases, microbiota-reactive CD4+ T cells were reduced in the blood compared with intestine; T-cell responses that we detected had an increased frequency of interleukin 17A production compared with responses of T cells from blood or intestinal tissues of controls. CONCLUSIONS: In an analysis of peripheral blood mononuclear cells and intestinal tissues from patients with inflammatory bowel diseases vs controls, we found that reactivity to intestinal bacteria is a normal property of the human CD4+ T-cell repertoire, and does not necessarily indicate disrupted interactions between immune cells and the commensal microbiota. T-cell responses to commensals might support intestinal homeostasis, by producing barrier-protective cytokines and providing a large pool of T cells that react to pathogens.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Hegazy AN, West NR, Stubbington MJT, et al. Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation. Gastroenterology. 2017. PMID: 28782508. doi:10.1053/j.gastro.2017.07.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。